Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de hormonación cruzada en el tratamiento de la disforia de género. Es ésta: (8/20) https://t.co/SS6PTOKYZi
Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Dec 2020 – Nov 2025Where it's discussed
-
X / Twitter113 posts
-
News9 articles
-
YouTube3 videos
AI synopsis
What people are saying
The analysis of social discussions reveals a prevalent concern about the paucity of high-quality studies on hormone therapy efficacy and safety, as seen in posts quoting the Cochrane review’s findings of insufficient evidence. Many posts question the legitimacy of current practices and emphasize the need for more rigorous research, with words like 'gap,' 'insufficient evidence,' and 'lack of studies' underscoring skepticism and a desire for better scientific grounding.
Most discussions highlight the lack of solid scientific evidence supporting current hormone treatments, indicating some skepticism or disagreement with prevalent practices.
The topic clearly sparks high interest, with many posts referencing reviews, studies, and calls for more research.
Participants engage actively with the topic by sharing links, quoting reviews, and discussing the implications, though not all delve deeply into scientific analysis.
The discussions raise awareness about gaps in research, but the immediate practical impact on clinical practice remains uncertain, hence a neutral score.
Abstract in brief
- Gender dysphoria is the psychological distress experienced by individuals whose gender identity differs from their assigned gender at birth, prompting a desire for physical transition through hormonal and surgical interventions.
- Current guidelines recommend hormone therapy for transgender women, utilizing options like estradiol and antiandrogens to promote desired female characteristics while acknowledging that surgery may be necessary for complete transition.
- The study aimed to evaluate the efficacy and safety of hormone therapies (both alone and in combination) in transitioning transgender women by analyzing data from various medical databases to include randomized controlled trials and cohort studies.
Top posts
Most liked on X and BlueskyA systematic review in Cochrane (IF 9.289): "We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition..." https://t.co/2Eh4jtHr7W
A November 2020 systematic review published in Cochrane “found insufficient evidence to determine the efficacy and safety of hormonal treatment for transgender women in transition.” https://t.co/ewjGvjKwFO
@amayadeakins @EmmaDiamonde @_CryMiaRiver What makes you think that the doctors know what the long term effects will be? The research hasn't been done. https://t.co/4YISrfbP84
@grace_huckins Don't miss these: UK- 2020 puberty blockers https://t.co/XPJKHJgkCL UK- 2020- hormones https://t.co/GRkSWlxIK3 INTL- Cochrane review- 2020 https://t.co/7ZBG3b5VWx
@bunny_betty @JaneSymons1 "We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition. This lack of studies shows a gap between current clinical practice and clinical research." https://t.co/4YISrfbP84
All mentions
Exploring Detransition: Insights from Gender Dysphoria Research
This video discusses a study involving 100 individuals who transitioned due to gender dysphoria and later detransitioned. Key findings highlight reasons for detransition, including personal comfort and insufficient…
Understanding Detransition: Insights from 100 Surveyed Individuals
This video explores insights from a survey of 100 individuals who transitioned due to gender dysphoria and later opted to detransition. Key reasons for this decision include personal comfort and medical concerns…
Understanding Detransition: Insights from Recent Research
This video explores a survey of 100 individuals who transitioned due to gender dysphoria and later detransitioned. It highlights key findings on the experiences and concerns surrounding medical transitions, emphasizing…
@FionaMattatall Direct from a Cochrane systematic review: Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women Our database searches identified 1057 references, and after removing duplicates we screened 787 of these. We checked 13 studies for
@PfParks Direct from a Cochrane systematic review: Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women Our database searches identified 1057 references, and after removing duplicates we screened 787 of these. We checked 13 studies for
@MarsJaneM @mcfluffypant @garylfrancione "This systematic review has shown that well‐designed, sufficiently robust randomised controlled trials (RCTs) and controlled‐cohort studies do not exist, and are needed, to assess the benefits and harms of hormone therapies" https://t.co/4YISrfbP84
@kimmydotzip https://t.co/4YISrfcmXC
@pataz1 @IsabeauVidal @HistoryBoomer The Cochrane Collaboration: https://t.co/UIjIFLYSKH Mayo: https://t.co/horL1kK6Dy Yale: https://t.co/QJ73G8vps1 Univ of Gothenburg: https://t.co/cz1TP3Gna4 Univ of Melbourne: https://t.co/AC1MkCW06s
@LainKaplan @SloaneFragment They use rats all the time in medical research. Would you prefer that they do what the gender quacks do and use people? "This lack of studies shows a gap between current clinical practice and clinical research." https://t.co/4YISrfcmXC
RT @Epicarmo33: @Sir_Martn @nacheldon @pessimist92548 @anacum3 Hay hasta estudios y metaanálosis bien hechos sobre los medicamentos que se…
@Sir_Martn @nacheldon @pessimist92548 @anacum3 Hay hasta estudios y metaanálosis bien hechos sobre los medicamentos que se usan para "transicionar". Como éste de la Librería Cochrane, que muestra como no hay evidencia científica que la respalde https://t.co/9KZP4vx2C1
@MsSweetTD @logic_on_sea @MagiGibson Here’s the Cochrane rev of x sex hormones in males. Which are linked with MS, Parkinson’s, CHD, cancer and blood clots. All of which sound like a worry to me. https://t.co/643iNLk0TI
RT @DarlaLek: @bunny_betty @JaneSymons1 "We found insufficient evidence to determine the efficacy or safety of hormonal treatment approache…
@TheatreSpoonie @JaneSymons1 Where is the evidence? "We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition. This lack of studies shows a gap between current clinical practice and clinical research." https://t.co/4YISrfbP84
@NickySimpson98 @JaneSymons1 "We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition. This lack of studies shows a gap between current clinical practice and clinical research." https://t.co/4YISrfbP84
@bunny_betty @JaneSymons1 "We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition. This lack of studies shows a gap between current clinical practice and clinical research." https://t.co/4YISrfbP84
@andrew_b72 @CarolineMack18 @JamieWhistle @CanSG_org Where is all the evidence that the gender crowd say that they have, but people carrying out systematic reviews can never find? Did you lose it down the back of the sofa? https://t.co/4YISrfbP84
@amayadeakins @EmmaDiamonde @_CryMiaRiver What makes you think that the doctors know what the long term effects will be? The research hasn't been done. https://t.co/4YISrfbP84
“We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition. This lack of studies shows a gap between current clinical practice and clinical research.” https://t.co/4ItY9xqZXZ
@rejserin @NevHawkins Worry about this. "We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition. This lack of studies shows a gap between current clinical practice and clinical research." https://t.co/4YISrfbP84
@VStRX6 @ima_pseudo41406 @KonstantinKisin "We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition. This lack of studies shows a gap between current clinical practice and clinical research." https://t.co/4YISrfbP84
@SoupTransphobes @Wizzard_life @mising0pX @WilliamQuirke4 A German study “found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition”, adding that “this lack of studies shows a gap between current clinical practice and clinical research.” https://t.co/d5MJY29LQR
@perdutaragazza9 https://t.co/mkGSLTlWnK https://t.co/HUv3agVydM https://t.co/nP8vyuDDLD https://t.co/l1UMSR56CW
@AusSkeptic @nana_surfing @sharrond62 You are welcome to pay for your own cosmetic surgeries if you are an adult. As for hormones, "the dose makes the poison". "This lack of studies shows a gap between current clinical practice and clinical research." https://t.co/4YISrfbP84
@oncloud_e The "laydee" doth protest too much. https://t.co/4YISrfbP84
@rejserin @eliottness555 @HJoyceGender Yes, and there is a dearth of good quality, long term studies into the effects. Why is that? https://t.co/4YISrfbP84
@ErinInTheMorn Show us some good quality long term research. Even better, forward it to these people. https://t.co/4YISrfbP84
@JessAurora464 @benappel @assignedmedia What research are those "major medical orgs" using as a basis for treatment? https://t.co/4YISrfbP84
@FrancescaElani @eva_kurilova You don't think that the British Medical Journal and the National Institute for Health and Care Excellence (NICE) are credible? Ok, try this. https://t.co/4YISrfbP84
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
RT @Jose__Errasti: Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de h…
Para cerrar este apartado, contamos también con una revisión Cochrane (las más prestigiosas del mundo) sobre el uso de hormonación cruzada en el tratamiento de la disforia de género. Es ésta: (8/20) https://t.co/SS6PTOKYZi
@ThatEricAlper Agreed! https://t.co/cXOtCcYvHG https://t.co/ilye1sm6ZT
Giving kids chemical castration has not been studied widely via a randomized control trial the way most medical intervention is required. (Claudia Haupt et al., “Antiandrogen or Estradiol Treatment or Both During Hormone Therapy in Transitioning Transgender Women,”)
https://t.co/139WlKhFdP
@StephanieJaneG6 @finite_planet @ParkWashli854 @AstralSunny @AidanCTweets https://t.co/lTZQeRESxG
@RBReich Let me get this straight. Democrats are for protecting children in some circumstances but support experimenting on them in others? Dems have an easy job. Be more attractive than the Trumpshirts. Stop with the Kool aid and check out evidence and experts. https://t.co/IJDSQSMnh2 https://t.co/GgaV13643l
@JandarSunstar69 @Peso1863 @stillgray https://t.co/cyYzPYv9fP
@MatthewOHerren1 https://t.co/cXOtCcYvHG
@bird_decoy @hfuriouss here's a link to the cochrane review https://t.co/CED5djSWn7
@kingbowski https://t.co/7TS8hdaxWo "Our review found no RCTs that looked at whether hormone therapies are effective and safe when used to help transgender women” - And you want us to publicly fund this when out health service is on it’s knees and people can’t even see a doctor for cancer?
@mindamurphy @Andsing49 @_oatc_ @DrLaurenWilson https://t.co/i4nD2DL3OD
@ArrowsNeo @mortenbc58 @JeffreyASachs Here are the links: BMJ article: https://t.co/KYI3xmI1ZS and references cited therein. Cass Review informing the NHS: https://t.co/CmWWNy5CDi Cochrane Review: https://t.co/FLwmgyPGWg Swedish Review: https://t.co/Cx11QxC7TH
“Authors' conclusions: We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition. This lack of studies shows a gap between current clinical practice and clinical research.” https://t.co/UilevSjAKU
@andreja_nienna @peace_ker_ "We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition." https://t.co/5v2744cvDK
@eff_off_now @johnnyfrederix @endofpatriarchy @k8souphead @francesweetman @TullipR https://t.co/STX3MAymPa https://t.co/BFNWpfjUwt https://t.co/Ipg8T9cRk8 https://t.co/3C2uoiO7bE
People concerned with gender treatment should be familiar with the Cochrane review of hormone therapy for transgender women. Incredibly, none of the studies examined until 2019 even met the criteria for inclusion, much less showing beneficial outcomes. https://t.co/5itir2P8Lq
@SraPetrillo @javiervoncount @estanteria_666 @_trovador__ El artículo enlaza a unos cuantos estudios cientificos. Pero pego unos pocos mas por aquí: https://t.co/P4a3iBBl99 https://t.co/Aa3T2S1Cr4
@JMSanchis70 @JuanaB1963 @ContraBorrado Revisión de la Cochrane Library, institución de máximo prestigio en cuanto a la revisión de la evidencia disponible en medicina. Sin conocer las consecuencias se ofrece a niños que no tienen capacidad de dar un consentimiento informado correcto. https://t.co/ejJmU2vg9h
RT @AntiAnja: @HildegardP @RoisinMichaux @PattyPeixinha @GussieGrips @heterodorx Yep. https://t.co/mGoe9n7DaS
@HildegardP @RoisinMichaux @PattyPeixinha @GussieGrips @heterodorx Yep. https://t.co/mGoe9n7DaS
@RohanIrvine @comingupcharlie @exfundyfeminist A German study “found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition”, adding “this lack of studies shows a gap between current clinical practice and clinical research". https://t.co/PxjqT7Y1Qh
RT @So_sick_of_all: Auch heftig. Cochrane findet in vorhandenen Studien ungenügende Evidenz um Wirksamkeit oder Sicherheit für hormonelle B…
Auch heftig. Cochrane findet in vorhandenen Studien ungenügende Evidenz um Wirksamkeit oder Sicherheit für hormonelle Behandlungsansätze bei #transgender Frauen. Aber die Behandlungspraxis funktioniert offenbar auch ohne. Gruselig. https://t.co/cjR59BJrEp https://t.co/Ug9gcvV383
RT @BillboardChris: A November 2020 systematic review published in Cochrane “found insufficient evidence to determine the efficacy and safe…
RT @BillboardChris: A November 2020 systematic review published in Cochrane “found insufficient evidence to determine the efficacy and safe…
@NNGG__Murcia @QMaebh @mosellanleftist @ScotNational https://t.co/4EaVHJ2aTq
RT @JeremyRedfernFL: A systematic review in Cochrane (IF 9.289): "We found insufficient evidence to determine the efficacy or safety of hor…
@SciSocialProbs @LeorSapir @SelterMosby Check out these rigorous, systematic reviews: FINLAND 2020 https://t.co/Ka6KNhhwSz SWEDEN- 2022 https://t.co/AFNJavtg87 UK 2020- NICE - puberty blockers https://t.co/XPJKHJfMNd UK 2020- NICE- hormones https://t.co/GRkSWlxaUv INTL Cochrane review- 202O https://t.co/7ZBG3b5o6Z
I see the last Cochrane review suffers from some obvious problems, including the demand for RCTs and dismissal of other evidence types, and no consideration of varying embodiment goals or bodily autonomy. https://t.co/bsxHLAJrMO
@grace_huckins Don't miss these: UK- 2020 puberty blockers https://t.co/XPJKHJgkCL UK- 2020- hormones https://t.co/GRkSWlxIK3 INTL- Cochrane review- 2020 https://t.co/7ZBG3b5VWx
RT @JeremyRedfernFL: A systematic review in Cochrane (IF 9.289): "We found insufficient evidence to determine the efficacy or safety of hor…
@SuperWeebshit @redfollowsred @tharook @Slimacusjimbozo @KatysCartoons https://t.co/Ic52PtVbJd
@CraveVoidStuffs @kagarinchanlife @krystalwolfy @Dezan888 @kofleor @ApollontheGreat @Casayana_ @Eebeedeebeee @WeMovinOnUp @Stylez0401 @Lauren_Southern @Timcast https://t.co/LijdD4pqiv
RT @BillboardChris: A November 2020 systematic review published in Cochrane “found insufficient evidence to determine the efficacy and safe…
RT @JeremyRedfernFL: A systematic review in Cochrane (IF 9.289): "We found insufficient evidence to determine the efficacy or safety of hor…
RT @JeremyRedfernFL: A systematic review in Cochrane (IF 9.289): "We found insufficient evidence to determine the efficacy or safety of hor…
RT @JeremyRedfernFL: A systematic review in Cochrane (IF 9.289): "We found insufficient evidence to determine the efficacy or safety of hor…
RT @JeremyRedfernFL: A systematic review in Cochrane (IF 9.289): "We found insufficient evidence to determine the efficacy or safety of hor…
@RosieRose112 @mid_capital @MeatEatingPony @lizlogan76 @greta @elonmusk Biologists put gender dysphoria in the DSM5 as a mental illness. Scientists have cast doubt on the treatments available (https://t.co/hJx6Ko3ED4). Also in play is language which is not in the realm of biology
@Jello92599417 https://t.co/rfA8xHkTmy https://t.co/Bgvuddky5M https://t.co/FB4yWB0JYx
RT @JeremyRedfernFL: A systematic review in Cochrane (IF 9.289): "We found insufficient evidence to determine the efficacy or safety of hor…
RT @JeremyRedfernFL: A systematic review in Cochrane (IF 9.289): "We found insufficient evidence to determine the efficacy or safety of hor…
RT @JeremyRedfernFL: A systematic review in Cochrane (IF 9.289): "We found insufficient evidence to determine the efficacy or safety of hor…
A systematic review in Cochrane (IF 9.289): "We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition..." https://t.co/2Eh4jtHr7W
RT @BillboardChris: A November 2020 systematic review published in Cochrane “found insufficient evidence to determine the efficacy and safe…
RT @CroneInAMillion: Anyone under 18 should not be prescribed puberty blockers or hormone therapy. Source (5 of 5): https://t.co/rY4NR9sFqj
Anyone under 18 should not be prescribed puberty blockers or hormone therapy. Source (5 of 5): https://t.co/rY4NR9sFqj
RT @BillboardChris: A November 2020 systematic review published in Cochrane “found insufficient evidence to determine the efficacy and safe…
A November 2020 systematic review published in Cochrane “found insufficient evidence to determine the efficacy and safety of hormonal treatment for transgender women in transition.” https://t.co/ewjGvjKwFO
@batujet @Ashley_Silver92 @UpTheRA03982085 @Fawkesyouguy https://t.co/Ic52PtVbJd https://t.co/WSjIYVwwdq
@CriticalCripple @DinosaurWitch @AphroditeRisin1 @nervewrvcking I understand it just fine and it doesn't back your position. https://t.co/HMxZSZrpv2
@xmarylawrence @stuartlosaltos @ladyheatherlee @SD57PG @BillboardChris Study done on adults reveals lack of evidence for safety or efficacy of cross hormones in TW. https://t.co/MlQ483Fzz9
@SharylJ3 @AphroditeRisin1 @BartySlarty @DictionaryAge @Debateisgood1 @BBCWomansHour @Emmabarnett Aw, they blocked me and I was just about to post this: https://t.co/FROEYi28LM
@UnderTheThunde2 https://t.co/c9Mvo8Kim2
@OffensiveLeftie @dahadooshtube https://t.co/c9Mvo8Kim2
@ComradeCutie @RedAndBlackFrog @KatyMontgomerie @NicESpurling @DutchDykes The Cochrane review which also found little to no evidence. https://t.co/c9Mvo8Kim2
@TransGirlTerra And this one https://t.co/YqV9WxgG8k
RT @FiLiA_charity: Cochrane Review states: 'We found insufficient evidence to determine the efficacy or safety of hormonal treatment appro…
@brennasaid @rustedbelts There have been several review papers in the last couple of years calling for better controlled studies, ex https://t.co/DyUHqGfiF2 https://t.co/643l8behdF https://t.co/U4B4lCHg0N https://t.co/zm1ONiJZbO https://t.co/22Z3uePQfV https://t.co/XO9rxmTGSt
https://t.co/cGCMxFgXIs https://t.co/dEPKUj1xC1 https://t.co/1bvHGRsUXr https://t.co/LoNj3zkaxT Ou sont les "EBM lovers" des bios twitter ? Tout le monde sait qu'on est en train de faire des conneries et probablement de dégâts importants, mais comme les LGBT vont hurler..
@GarthMarenghia @PhoenixRedRum @TooMarianne @imjamesbarr @thismorning https://t.co/pHYQPVeZAf
@KeelieSturm @delinquente_la @reads_long @KnownHeretic @chasestrangio Authors' conclusions We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition. https://t.co/TIrRDU9QNX
@niki_dev @1Jhost1 @lacroicsz I prefer not to link spam, but you seem oblivious to the weight of research you need to disprove. They all agree it's far from "well established". https://t.co/Cyr1I7vA5R https://t.co/mRnqxgHiC5 https://t.co/PcOkwyZAf9 https://t.co/HpC7fDCLS9 https://t.co/LHOucln2yR
@kitsumption @Adams68Callum @trampledrose_xx @jordanbpeterson https://t.co/BCDltoId2n There's a Cochrane one which gave trans medicine the same treatment as other medical fields get, with unsurprising results.
@sand_kinnie @ArmyTeacake @BlakemanChelsea @NYCSorceress @tibby17 @sexhale @Boeing74 @TheTomGeorge @TulsiGabbard @KITV4 https://t.co/Is3PTJZqf3
@inkytalons @dixiechick547 @_HelenDale @SandyDrawsBadly @CapX https://t.co/qFnv3pQf9H https://t.co/b3SDmQv8oH https://t.co/iKkaxdqxY0 https://t.co/UWNzAHqKhi https://t.co/wT6K55ngvq
RT @FiLiA_charity: Cochrane Review states: 'We found insufficient evidence to determine the efficacy or safety of hormonal treatment appro…
RT @lascapigliata8: @GloriaSlap @Sparrlyten @AlessandraAster @HJoyceGender @joshwoolcott @SVPhillimore @AudreySuffolk Trans research in gen…
@GloriaSlap @Sparrlyten @AlessandraAster @HJoyceGender @joshwoolcott @SVPhillimore @AudreySuffolk Trans research in general is of extremely low quality, see clr example the latest Cochrane review https://t.co/K5EvriqnDH https://t.co/7Rc0kDMHBz
RT @FiLiA_charity: Cochrane Review states: 'We found insufficient evidence to determine the efficacy or safety of hormonal treatment appro…
RT @feline_charm: Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women - Haupt, C - 2020 |…
Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women - Haupt, C - 2020 | Cochrane Library https://t.co/vjXVWilcP3 Interested to hear your comments @DebbieHayton, @maxanium?
Great thread explaining the evidence of the Cochrane Review 'Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women' https://t.co/jNIYuXJ2ka https://t.co/EGIO48l4hX
Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women. https://t.co/UhDWFrJ2u5 #PubMed #Transgender
JE
JR
BC
DL
G
M
A
PX
E
EE
BG
L
TM
H
BX
CQ
JS
Y
PL
W
ÁT
NB
M
A
A
L
PS
S
SM
D
FH
W
CF
GD
MK
J
RP
OZ
SW
A
F
RM
A
PL
M
SN
A
AH
E
DH
SF
TN
KT
DM
JD
C
ES
P
JH
MB
P
MC
B
F
BB
S
N
BH
MM
KJ
E
BB
K
HR
JW
SK
LS
R
LN
EM
E
AN
TL
T